According to Sonoma Pharmaceuticals latest financial reports the cash on hand of SNOA is $3.82M, an decrease of -48.35% to 2022. At the end of 2022 company had $7.40M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $3.82M | -48.35% |
2022 | $7.40M | 75.26% |
2021 | $4.22M | 14.33% |
2020 | $3.69M | 0.05% |
2019 | $3.69M | - |